Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × Crizotinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Multiple Myeloma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Hematologic Neoplasms 1 Granuloma, Plasma Cell 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Carboplatin 15 pembrolizumab 13 Specimen Handling 12 Paclitaxel 11 Gemcitabine 9 130-nm albumin-bound paclitaxel 9 Taxes 8 Magnetic Resonance Spectroscopy 8 Capecitabine 7 Biopsy 7 Albumin-Bound Paclitaxel 7 sacituzumab govitecan 5 Cyclophosphamide 4 Cisplatin 4 Radiotherapy 3 Radiation 3 Bevacizumab 3 fludarabine 2 famitinib 2 eribulin 2 binimetinib 2 avelumab 2 abemaciclib 2 Platinum 2 Nivolumab 2 Immunoglobulin G 2 Everolimus 2 Epirubicin 2 Docetaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡